PALLADIA is Now Available!
Oncology Service Offers Pfizer's New Canine Cancer Therapy
We are now able to offer PALLADIA (Pfizer) to our patients.
On June 3rd, the FDA approved the first canine cancer therapy, as Pfizer Animal Health received approval for PALLADIA.
PALLADIA (toceranib phosphate) was developed to treat canine mast cell tumors (MCT). PALLADIA is an oral therapy indicated to treat Patnaik grade II or III MCT with or without regional lymph node involvement.
Ask your primary care veterinarian to contact Andrew Novosad, DVM, DACVIM, at 281-491-7800 to discuss this exciting new treatment option.
